Artiva Biotherapeutics, Inc. (ARTV) › Operating IncomeArtiva Biotherapeutics, Inc. (ARTV) — Operating IncomeAnnual figures by period end, from SEC filings.2023-12-31: -$30.67M2024-12-31: -$67.28M2025-12-31: -$89.81M-$89.81M2023-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$89.81M—2026-03-10From 2025-01-012024-12-31-$67.28M—2026-03-10From 2024-01-012023-12-31-$30.67M—2025-03-24From 2023-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)